IN149973B - - Google Patents

Info

Publication number
IN149973B
IN149973B IN19/DEL/81A IN19DE1981A IN149973B IN 149973 B IN149973 B IN 149973B IN 19DE1981 A IN19DE1981 A IN 19DE1981A IN 149973 B IN149973 B IN 149973B
Authority
IN
India
Application number
IN19/DEL/81A
Other languages
English (en)
Inventor
S Campbell
J Danilewicz
A Evans
A Ham
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IN19/DEL/81A priority Critical patent/IN149973B/en
Publication of IN149973B publication Critical patent/IN149973B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IN19/DEL/81A 1977-06-03 1981-01-13 IN149973B (US20030186963A1-20031002-C00002.png)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN19/DEL/81A IN149973B (US20030186963A1-20031002-C00002.png) 1977-06-03 1981-01-13

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2358277 1977-06-03
IN364/DEL/78A IN148482B (US20030186963A1-20031002-C00002.png) 1977-06-03 1978-05-15
IN19/DEL/81A IN149973B (US20030186963A1-20031002-C00002.png) 1977-06-03 1981-01-13

Publications (1)

Publication Number Publication Date
IN149973B true IN149973B (US20030186963A1-20031002-C00002.png) 1982-06-19

Family

ID=10198020

Family Applications (3)

Application Number Title Priority Date Filing Date
IN364/DEL/78A IN148482B (US20030186963A1-20031002-C00002.png) 1977-06-03 1978-05-15
IN368/DEL/80A IN149550B (US20030186963A1-20031002-C00002.png) 1977-06-03 1980-05-20
IN19/DEL/81A IN149973B (US20030186963A1-20031002-C00002.png) 1977-06-03 1981-01-13

Family Applications Before (2)

Application Number Title Priority Date Filing Date
IN364/DEL/78A IN148482B (US20030186963A1-20031002-C00002.png) 1977-06-03 1978-05-15
IN368/DEL/80A IN149550B (US20030186963A1-20031002-C00002.png) 1977-06-03 1980-05-20

Country Status (29)

Country Link
US (1) US4289772A (US20030186963A1-20031002-C00002.png)
JP (1) JPS5416488A (US20030186963A1-20031002-C00002.png)
AR (2) AR222013A1 (US20030186963A1-20031002-C00002.png)
AT (2) AT362792B (US20030186963A1-20031002-C00002.png)
AU (1) AU505373B1 (US20030186963A1-20031002-C00002.png)
BE (1) BE867727A (US20030186963A1-20031002-C00002.png)
CA (1) CA1111850A (US20030186963A1-20031002-C00002.png)
DD (1) DD137355A5 (US20030186963A1-20031002-C00002.png)
DE (1) DE2824064A1 (US20030186963A1-20031002-C00002.png)
DK (1) DK248078A (US20030186963A1-20031002-C00002.png)
EG (1) EG13527A (US20030186963A1-20031002-C00002.png)
ES (4) ES470470A1 (US20030186963A1-20031002-C00002.png)
FI (1) FI781753A (US20030186963A1-20031002-C00002.png)
FR (1) FR2392986A1 (US20030186963A1-20031002-C00002.png)
GB (1) GB2000136B (US20030186963A1-20031002-C00002.png)
GR (1) GR74402B (US20030186963A1-20031002-C00002.png)
HU (1) HU179745B (US20030186963A1-20031002-C00002.png)
IL (1) IL54842A (US20030186963A1-20031002-C00002.png)
IN (3) IN148482B (US20030186963A1-20031002-C00002.png)
IT (1) IT1094944B (US20030186963A1-20031002-C00002.png)
LU (1) LU79761A1 (US20030186963A1-20031002-C00002.png)
NL (1) NL7806016A (US20030186963A1-20031002-C00002.png)
NO (1) NO781935L (US20030186963A1-20031002-C00002.png)
NZ (1) NZ187453A (US20030186963A1-20031002-C00002.png)
PL (3) PL116437B1 (US20030186963A1-20031002-C00002.png)
PT (1) PT68126A (US20030186963A1-20031002-C00002.png)
SE (1) SE7806519L (US20030186963A1-20031002-C00002.png)
SU (2) SU856383A3 (US20030186963A1-20031002-C00002.png)
ZA (1) ZA783183B (US20030186963A1-20031002-C00002.png)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
IL59619A0 (en) * 1979-03-28 1980-06-30 Pfizer Phthalazine derivatives,their preparation and pharmaceutical compositions containing them
CA1173037A (en) * 1980-03-01 1984-08-21 John L. Archibald Piperidino ureas as antidepressants
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
EP0621267A1 (en) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidine derivatives and their use as fungicides
AU5772196A (en) * 1995-05-19 1996-11-29 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
CN1121220C (zh) * 1996-08-20 2003-09-17 卫材株式会社 稠合哒嗪系化合物的勃起机能不全症治疗剂
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
RU2333210C2 (ru) * 2002-08-16 2008-09-10 Янссен Фармацевтика Н.В. Соединения пиперидинила, селективно связывающие интегрины
US20040224986A1 (en) * 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
JP2009524637A (ja) * 2006-01-27 2009-07-02 ファイザー・プロダクツ・インク アミノフタラジン誘導体化合物
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007110449A1 (en) 2006-03-29 2007-10-04 Euro-Celtique S.A. Benzenesulfonamide compounds and their use
TW200812963A (en) 2006-04-13 2008-03-16 Euro Celtique Sa Benzenesulfonamide compounds and the use thereof
US8791264B2 (en) 2006-04-13 2014-07-29 Purdue Pharma L.P. Benzenesulfonamide compounds and their use as blockers of calcium channels
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
EP1900731A1 (de) * 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008124118A1 (en) 2007-04-09 2008-10-16 Purdue Pharma L.P. Benzenesulfonyl compounds and the use therof
RU2010106974A (ru) 2007-08-07 2011-09-20 Ф.Хоффманн-Ля Рош Аг (Ch) Ариловые эфиры пирролидина в качестве антагонистов рецепторов nk3
ATE519738T1 (de) 2007-08-22 2011-08-15 Hoffmann La Roche Pyrrolidinarylether als nk3-rezeptorantagonisten
CA2699464A1 (en) * 2007-09-14 2009-03-19 F. Hoffmann-La Roche Ag Piperidine derivatives as nk3 receptor antagonists
WO2009040659A2 (en) 2007-09-28 2009-04-02 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077014A1 (es) * 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
CN113087654B (zh) * 2021-04-15 2022-12-23 苏州昊帆生物股份有限公司 哌啶-4-丁胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094044A (en) * 1965-07-12 1967-12-06 Vantorex Ltd Phthalazine derivatives
GB1199768A (en) 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
GB1460389A (en) 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
IN148482B (US20030186963A1-20031002-C00002.png) 1981-03-07
US4289772A (en) 1981-09-15
SU856383A3 (ru) 1981-08-15
FI781753A (fi) 1978-12-04
IT7824106A0 (it) 1978-06-01
CA1111850A (en) 1981-11-03
JPS5538351B2 (US20030186963A1-20031002-C00002.png) 1980-10-03
IT1094944B (it) 1985-08-10
PL207337A1 (pl) 1979-06-04
GB2000136B (en) 1982-01-06
LU79761A1 (fr) 1980-01-22
PL116437B1 (en) 1981-06-30
FR2392986A1 (fr) 1978-12-29
PL116420B1 (en) 1981-06-30
DK248078A (da) 1978-12-04
GR74402B (US20030186963A1-20031002-C00002.png) 1984-06-28
ATA400878A (de) 1980-11-15
BE867727A (fr) 1978-12-01
IL54842A (en) 1982-01-31
AT362792B (de) 1981-06-10
HU179745B (en) 1982-12-28
AR223999A1 (es) 1981-10-15
JPS5416488A (en) 1979-02-07
ES478199A1 (es) 1980-01-16
NL7806016A (nl) 1978-12-05
FR2392986B1 (US20030186963A1-20031002-C00002.png) 1982-07-16
EG13527A (en) 1981-12-31
SE7806519L (sv) 1978-12-04
PL113208B1 (en) 1980-11-29
ES478200A1 (es) 1980-01-01
ES470470A1 (es) 1979-09-01
ES478201A1 (es) 1980-02-01
ZA783183B (en) 1979-06-27
GB2000136A (en) 1979-01-04
NO781935L (no) 1978-12-05
ATA305080A (de) 1980-12-15
IL54842A0 (en) 1978-08-31
IN149550B (US20030186963A1-20031002-C00002.png) 1982-01-16
SU862826A3 (ru) 1981-09-07
PT68126A (en) 1978-07-01
DE2824064A1 (de) 1978-12-14
DD137355A5 (de) 1979-08-29
AU505373B1 (en) 1979-11-15
AT363096B (de) 1981-07-10
NZ187453A (en) 1980-12-19
AR222013A1 (es) 1981-04-15

Similar Documents

Publication Publication Date Title
FR2377166B1 (US20030186963A1-20031002-C00002.png)
FR2392986B1 (US20030186963A1-20031002-C00002.png)
DE2752514C2 (US20030186963A1-20031002-C00002.png)
DE2750735C2 (US20030186963A1-20031002-C00002.png)
FR2376898B1 (US20030186963A1-20031002-C00002.png)
DE2803939C2 (US20030186963A1-20031002-C00002.png)
BG25839A1 (US20030186963A1-20031002-C00002.png)
BG25834A1 (US20030186963A1-20031002-C00002.png)
BG25855A1 (US20030186963A1-20031002-C00002.png)
BG25853A1 (US20030186963A1-20031002-C00002.png)
BG25852A1 (US20030186963A1-20031002-C00002.png)
BG25851A1 (US20030186963A1-20031002-C00002.png)
BG25850A1 (US20030186963A1-20031002-C00002.png)
BG25848A1 (US20030186963A1-20031002-C00002.png)
BG25847A1 (US20030186963A1-20031002-C00002.png)
BG25845A1 (US20030186963A1-20031002-C00002.png)
BG25844A1 (US20030186963A1-20031002-C00002.png)
BG25841A1 (US20030186963A1-20031002-C00002.png)
BG25840A1 (US20030186963A1-20031002-C00002.png)
BG26474A1 (US20030186963A1-20031002-C00002.png)
BG25838A1 (US20030186963A1-20031002-C00002.png)
CH598847A5 (US20030186963A1-20031002-C00002.png)
CH605178A5 (US20030186963A1-20031002-C00002.png)
CH609774A5 (US20030186963A1-20031002-C00002.png)
BG25837A1 (US20030186963A1-20031002-C00002.png)